BACKGROUND: Angelman- and Rett-like syndromes share a range of clinical characteristics, including intellectual disability (ID) with or without regression, epilepsy, infantile encephalopathy, postnatal microcephaly, features of autism spectrum disorder, and variable other neurological symptoms. The phenotypic spectrum generally has been well studied in children; however, evolution of the phenotypic spectrum into adulthood has been documented less extensively. To obtain more insight into natural course and prognosis of these syndromes with respect to developmental, medical, and socio-behavioral outcomes, we studied the phenotypes of 9 adult patients who were recently diagnosed with 6 different Angelman- and Rett-like syndromes. METHODS: All these patients were ascertained during an ongoing cohort study involving a systematic clinical genetic diagnostic evaluation of over 250, mainly adult patients with ID of unknown etiology. RESULTS: We describe the evolution of the phenotype in adults with EHMT1, TCF4, MECP2, CDKL5, and SCN1A mutations and 22qter deletions and also provide an overview of previously published adult cases with similar diagnoses. CONCLUSION: These data are highly valuable in adequate management and follow-up of patients with Angelman- and Rett-like syndromes and accurate counseling of their family members. Furthermore, they will contribute to recognition of these syndromes in previously undiagnosed adult patients.
BACKGROUND: Angelman- and Rett-like syndromes share a range of clinical characteristics, including intellectual disability (ID) with or without regression, epilepsy, infantile encephalopathy, postnatal microcephaly, features of autism spectrum disorder, and variable other neurological symptoms. The phenotypic spectrum generally has been well studied in children; however, evolution of the phenotypic spectrum into adulthood has been documented less extensively. To obtain more insight into natural course and prognosis of these syndromes with respect to developmental, medical, and socio-behavioral outcomes, we studied the phenotypes of 9 adult patients who were recently diagnosed with 6 different Angelman- and Rett-like syndromes. METHODS: All these patients were ascertained during an ongoing cohort study involving a systematic clinical genetic diagnostic evaluation of over 250, mainly adult patients with ID of unknown etiology. RESULTS: We describe the evolution of the phenotype in adults with EHMT1, TCF4, MECP2, CDKL5, and SCN1A mutations and 22qter deletions and also provide an overview of previously published adult cases with similar diagnoses. CONCLUSION: These data are highly valuable in adequate management and follow-up of patients with Angelman- and Rett-like syndromes and accurate counseling of their family members. Furthermore, they will contribute to recognition of these syndromes in previously undiagnosed adult patients.
Authors: Markus Zweier; Anne Gregor; Christiane Zweier; Hartmut Engels; Heinrich Sticht; Eva Wohlleber; Emilia K Bijlsma; Susan E Holder; Martin Zenker; Eva Rossier; Ute Grasshoff; Diana S Johnson; Lisa Robertson; Helen V Firth; Arif B Ekici; André Reis; Anita Rauch Journal: Hum Mutat Date: 2010-06 Impact factor: 4.878
Authors: A Orrico; C Lam; L Galli; M T Dotti; G Hayek; S F Tong; P M Poon; M Zappella; A Federico; V Sorrentino Journal: FEBS Lett Date: 2000-09-22 Impact factor: 4.124
Authors: Ute Moog; Eric E J Smeets; Kees E P van Roozendaal; Sam Schoenmakers; Jos Herbergs; Anneke M J Schoonbrood-Lenssen; Connie T R M Schrander-Stumpel Journal: Eur J Paediatr Neurol Date: 2003 Impact factor: 3.140
Authors: Marie Gomot; Chantal Gendrot; Alain Verloes; Martine Raynaud; Albert David; Helger G Yntema; Sabine Dessay; Vera Kalscheuer; Suzanne Frints; Philippe Couvert; Sylvain Briault; Sophie Blesson; Annick Toutain; Jamel Chelly; Vincent Desportes; Claude Moraine Journal: Am J Med Genet A Date: 2003-12-01 Impact factor: 2.802
Authors: Tjitske Kleefstra; Helger G Yntema; Willy M Nillesen; Astrid R Oudakker; Reinier A Mullaart; Niels Geerdink; Hans van Bokhoven; Bert B A de Vries; Erik A Sistermans; Ben C J Hamel Journal: Eur J Hum Genet Date: 2004-01 Impact factor: 4.246
Authors: H L Wilson; A C C Wong; S R Shaw; W-Y Tse; G A Stapleton; M C Phelan; S Hu; J Marshall; H E McDermid Journal: J Med Genet Date: 2003-08 Impact factor: 6.318
Authors: T Kleefstra; H G Yntema; A R Oudakker; T Romein; E Sistermans; W Nillessen; H van Bokhoven; B B A de Vries; B C J Hamel Journal: Clin Genet Date: 2002-05 Impact factor: 4.438
Authors: S Russo; M Marchi; F Cogliati; M T Bonati; M Pintaudi; E Veneselli; V Saletti; M Balestrini; B Ben-Zeev; L Larizza Journal: Neurogenetics Date: 2009-02-25 Impact factor: 2.660
Authors: S Claes; K Devriendt; P D'Adamo; J Meireleire; P Raeymaekers; D Toniolo; J J Cassiman; J P Fryns Journal: Clin Genet Date: 1997-09 Impact factor: 4.438
Authors: I-Ting Judy Wang; Megan Allen; Darren Goffin; Xinjian Zhu; Andrew H Fairless; Edward S Brodkin; Steve J Siegel; Eric D Marsh; Julie A Blendy; Zhaolan Zhou Journal: Proc Natl Acad Sci U S A Date: 2012-12-10 Impact factor: 11.205
Authors: Jiani Yin; Chun-An Chun; Nikolay N Zavadenko; Natalia L Pechatnikova; Oxana Yu Naumova; Harsha V Doddapaneni; Jianhong Hu; Donna M Muzny; Christian P Schaaf; Elena L Grigorenko Journal: Genes (Basel) Date: 2020-07-25 Impact factor: 4.096
Authors: A Özge Sungur; Tobias M Redecker; Elena Andres; Wiebke Dürichen; Rainer K W Schwarting; Adriana Del Rey; Markus Wöhr Journal: Front Mol Neurosci Date: 2018-11-16 Impact factor: 5.639